2010
DOI: 10.1007/978-3-642-12020-6_51
|View full text |Cite
|
Sign up to set email alerts
|

Formation of Biodegradable Copolymeric Nanoparticles for Anticancer Drug Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 8 publications
1
4
0
Order By: Relevance
“…According to the results, the antibacterial effect of m-PEG/PCL/eugenol was greater than the free eugenol at equal concentration and it was different against gram-positive and gram-negative bacteria (28). This nding can be interpreted by the improved properties of eugenol through loading into the polymeric nanoparticles in terms of antibacterial e ciency, stability, and drug solubility (29). The outcomes are consistent with past studies.…”
Section: Bacteria Growth Ratesupporting
confidence: 89%
“…According to the results, the antibacterial effect of m-PEG/PCL/eugenol was greater than the free eugenol at equal concentration and it was different against gram-positive and gram-negative bacteria (28). This nding can be interpreted by the improved properties of eugenol through loading into the polymeric nanoparticles in terms of antibacterial e ciency, stability, and drug solubility (29). The outcomes are consistent with past studies.…”
Section: Bacteria Growth Ratesupporting
confidence: 89%
“…Recent studies of drug-loaded polymeric micelles showed enhanced characteristics of these materials, such as antibacterial efficiency, stability, drug solubility, and selective targeting [ 8 , 9 ]. Poly(ε-caprolactone) (PCL) has been studied as an ideal material for drug delivery because of its adjustable degradation time [ 8 , 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Recent studies of drug-loaded polymeric micelles showed enhanced characteristics of these materials, such as antibacterial efficiency, stability, drug solubility, and selective targeting [ 8 , 9 ]. Poly(ε-caprolactone) (PCL) has been studied as an ideal material for drug delivery because of its adjustable degradation time [ 8 , 10 , 11 ]. On the contrary, poly(ethylene glycol) (PEG) is a water-soluble, non-toxic molecule that has no antigenicity immunogenicity and can thus co-polymerize with ε-caprolactone (ε-CL) to take advantage of its improved bioavailability and biodegradation as well as mild toxicity [ 8 , 10 , 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…These characteristics included gel attributes, pharmacokinetics, morphology, effectiveness against cancer, and immune-histopathology. A more recent study demonstrated that several nanocarriers, including the bio-nano-capsule-liposome nanocarrier [ 134 ], poly(benzyl-L-aspartate)-co-[N-(3-aminopropyl) imidazole-L-aspartamide]-poly(ethylene glycol) [ 135 ], polysaccharide-based carriers [ 136 ], and poly(aspartic acid-graft Epsilon-caprolactone polymerized with poly(ethylene glycol) [ 137 ], were shown to be safe in vivo when being used to treat intestinal inflammation and malignancies. Although a wide range of nanocarriers are being developed, several of them are currently going through sophisticated clinical testing.…”
Section: Safety Evaluation Of Lipid-based Nanoparticles Encapsulating...mentioning
confidence: 99%